key: cord-0859296-j34ved0k
authors: Ayatollahi, Azin; Robati, Reza M.; Firooz, Alireza
title: Plantar herpes zoster following heterologous recombinant adenovirus‐based COVID‐19 vaccine
date: 2021-11-10
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14605
sha: 47a1b5f1a14b961b1f17e5e9b4de51a4606b5427
doc_id: 859296
cord_uid: j34ved0k

nan

To the best of our knowledge, our case could be a distinctive report of herpes zoster after recombinant adenovirus (rAd)-based COVID-19 vaccine and the plantar location of the HZ lesions has also been reported less frequently. In our opinion, the immune dysregulation caused by vaccination may play a role in the reactivation of latent VZV.

Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials

Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study

Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence?

Herpes zoster after inactivated COVID-19 vaccine: a cutaneous adverse effect of the vaccine

Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series

Varicella zoster virus reactivation following COVID-19 vaccination: a systematic review of case reports

Controversy surrounding the Sputnik V vaccine